Stocks Running Out of Cash — Months-of-Runway Tracker
Public companies with negative operating cash flow in their most recent SEC filing, ranked ascending by months-of-runway. Runway is computed directly from XBRL-tagged us-gaap:CashAndCashEquivalentsAtCarryingValue and us-gaap:NetCashProvidedByUsedInOperatingActivities — no AI-generated figures. 2,694 qualifying issuers (785 extreme, 435 high, 448 medium, 1,026 low).
| Ticker | Company | Runway | Severity | Cash | Monthly burn | Period | Filed | EDGAR |
|---|---|---|---|---|---|---|---|---|
| GENB | Generate Biomedicines, Inc. | 6.0 mo | medium | $160.57M | $26.80M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| AUTL | Autolus Therapeutics plc | 6.0 mo | medium | $130.93M | $21.77M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| CHRS | Coherus Oncology, Inc. | 6.0 mo | medium | $115.24M | $19.30M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| AVD | AMERICAN VANGUARD CORP | 6.0 mo | medium | $70.91M | $11.81M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| PMVP | PMV Pharmaceuticals, Inc. | 6.0 mo | medium | $39.13M | $6.56M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| QTRX | Quanterix Corp | 6.0 mo | medium | $36.18M | $6.04M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| SCNX | Scienture Holdings, Inc. | 6.0 mo | medium | $6.66M | $1.11M | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| DNMX | Dynamix Corp III | 6.0 mo | medium | $1.01M | $167.2K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| CBRE | CBRE GROUP, INC. | 6.1 mo | medium | $1.66B | $275.00M | 3mo · Mar 31, 2026 | 10-Q · Apr 23, 2026 | view |
| SHOO | STEVEN MADDEN, LTD. | 6.1 mo | medium | $112.42M | $18.45M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| UPB | Upstream Bio, Inc. | 6.1 mo | medium | $96.72M | $15.95M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| CCCC | C4 Therapeutics, Inc. | 6.1 mo | medium | $61.27M | $9.98M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| IPSC | Century Therapeutics, Inc. | 6.1 mo | medium | $51.05M | $8.42M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| CRKN | Crown Electrokinetics Corp. | 6.1 mo | medium | $22.45M | $3.67M | 3mo · Mar 31, 2025 | 10-Q · May 15, 2025 | view |
| LMB | Limbach Holdings, Inc. | 6.1 mo | medium | $15.77M | $2.60M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| CION | CION Investment Corp | 6.1 mo | medium | $9.25M | $1.52M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| RNGR | Ranger Energy Services, Inc. | 6.1 mo | medium | $6.90M | $1.13M | 3mo · Mar 31, 2026 | 10-Q · Apr 28, 2026 | view |
| BRN | BARNWELL INDUSTRIES INC | 6.1 mo | medium | $3.62M | $589.0K | 3mo · Dec 31, 2025 | 10-Q · Feb 23, 2026 | view |
| CBRRF | Chain Bridge I | 6.1 mo | medium | $390.3K | $63.6K | 12mo · Dec 31, 2025 | 10-K · Apr 1, 2026 | view |
| MARA | MARA Holdings, Inc. | 6.2 mo | medium | $513.65M | $82.50M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| VIR | Vir Biotechnology, Inc. | 6.2 mo | medium | $274.16M | $44.13M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| SEB | SEABOARD CORP /DE/ | 6.2 mo | medium | $111.00M | $18.00M | 3mo · Apr 4, 2026 | 10-Q · May 5, 2026 | view |
| XGN | EXAGEN INC. | 6.2 mo | medium | $21.51M | $3.47M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| AUMN | Golden Minerals Co | 6.2 mo | medium | $2.50M | $403.7K | 6mo · Jun 30, 2025 | 10-Q · Aug 14, 2025 | view |
| BHIC | BioScience Health Innovations, Inc. | 6.2 mo | medium | $1.15M | $184.0K | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| KW | Kennedy-Wilson Holdings, Inc. | 6.3 mo | medium | $184.60M | $29.30M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| IDYA | IDEAYA Biosciences, Inc. | 6.3 mo | medium | $157.52M | $25.06M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| PCT | PureCycle Technologies, Inc. | 6.3 mo | medium | $90.21M | $14.22M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| ORKA | Oruka Therapeutics, Inc. | 6.3 mo | medium | $49.52M | $7.86M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| MRT | Marti Technologies, Inc. | 6.3 mo | medium | $7.81M | $1.23M | 12mo · Dec 31, 2025 | 20-F · Apr 13, 2026 | view |
| GTBP | GT Biopharma, Inc. | 6.3 mo | medium | $6.81M | $1.08M | 12mo · Dec 31, 2025 | 10-K · Mar 2, 2026 | view |
| IDAI | T Stamp Inc | 6.3 mo | medium | $3.89M | $619.2K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| KWIK | KwikClick, Inc. | 6.3 mo | medium | $106.5K | $16.8K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| BK | Bank of New York Mellon Corp | 6.4 mo | medium | $6.39B | $1.00B | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| ALKS | Alkermes plc. | 6.4 mo | medium | $351.55M | $55.25M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| FBRT | Franklin BSP Realty Trust, Inc. | 6.4 mo | medium | $115.60M | $18.00M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| ABOS | Acumen Pharmaceuticals, Inc. | 6.4 mo | medium | $51.80M | $8.04M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| LNZA | LanzaTech Global, Inc. | 6.4 mo | medium | $19.86M | $3.09M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| LOOP | Loop Industries, Inc. | 6.4 mo | medium | $5.20M | $819.1K | 9mo · Nov 30, 2025 | 10-Q · Jan 14, 2026 | view |
| POSC | POSITRON CORP | 6.4 mo | medium | $2.52M | $391.7K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| MITQ | MOVING iMAGE TECHNOLOGIES INC. | 6.4 mo | medium | $2.36M | $366.8K | 9mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| AIDX | 20/20 Biolabs, Inc. | 6.4 mo | medium | $1.03M | $160.0K | 12mo · Dec 31, 2025 | S-1 · Apr 6, 2026 | view |
| LOBO | LOBO TECHNOLOGIES LTD. | 6.4 mo | medium | $908.3K | $141.8K | 12mo · Dec 31, 2025 | 20-F · Apr 28, 2026 | view |
| MRLN | Merlin, Inc. | 6.4 mo | medium | $703.6K | $110.7K | 12mo · Dec 31, 2025 | S-1 · May 6, 2026 | view |
| MBI | MBIA INC | 6.5 mo | medium | $72.00M | $11.00M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ICTSF | ICTS INTERNATIONAL N V | 6.5 mo | medium | $16.89M | $2.58M | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| ITRM | Iterum Therapeutics plc | 6.5 mo | medium | $11.00M | $1.70M | 9mo · Sep 30, 2025 | 10-Q · Nov 14, 2025 | view |
| DYAI | DYADIC INTERNATIONAL INC | 6.5 mo | medium | $4.25M | $654.4K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| TAOX | TAO Synergies Inc. | 6.5 mo | medium | $3.65M | $561.0K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| PTIX | Protagenic Therapeutics, Inc.new | 6.5 mo | medium | $2.21M | $341.4K | 9mo · Dec 31, 2025 | 10-Q · Mar 9, 2026 | view |
| BKYI | BIO KEY INTERNATIONAL INC | 6.5 mo | medium | $2.04M | $315.3K | 9mo · Sep 30, 2025 | 10-Q · Nov 14, 2025 | view |
| TRLEF | Trillion Energy International Inc. | 6.5 mo | medium | $1.03M | $157.0K | 12mo · Dec 31, 2021 | 20-F · May 2, 2022 | view |
| PDC | Perpetuals.com Ltd | 6.5 mo | medium | $731.8K | $112.0K | 12mo · Apr 30, 2025 | 20-F · Aug 27, 2025 | view |
| GSIW | Garden Stage Ltd | 6.5 mo | medium | $624.6K | $95.7K | 12mo · Mar 31, 2025 | 20-F · Jul 31, 2025 | view |
| ODYY | Odyssey Health, Inc. | 6.5 mo | medium | $616.3K | $94.7K | 6mo · Jan 31, 2026 | 10-Q · Mar 12, 2026 | view |
| MGAM | Mobile Global Esports, Inc. | 6.5 mo | medium | $573.3K | $88.9K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| KDK | Kodiak AI, Inc. | 6.6 mo | medium | $64.95M | $9.83M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| MVIS | MICROVISION, INC. | 6.6 mo | medium | $32.36M | $4.89M | 12mo · Dec 31, 2025 | 10-K · Mar 4, 2026 | view |
| LYRA | Lyra Therapeutics, Inc. | 6.6 mo | medium | $15.89M | $2.40M | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| NRXP | NRX Pharmaceuticals, Inc. | 6.6 mo | medium | $7.80M | $1.18M | 12mo · Dec 31, 2025 | 10-K · Mar 23, 2026 | view |
| SLXN | Silexion Therapeutics Corp | 6.6 mo | medium | $5.99M | $901.6K | 12mo · Dec 31, 2025 | 10-K · Mar 17, 2026 | view |
| ENSC | Ensysce Biosciences, Inc. | 6.6 mo | medium | $4.31M | $650.5K | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| ZEOX | Zeo ScientifiX, Inc. | 6.6 mo | medium | $1.03M | $157.0K | 3mo · Jan 31, 2026 | 10-Q · Mar 17, 2026 | view |
| SKVI | SKINVISIBLE, INC. | 6.6 mo | medium | $1.8K | $274 | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| FLNC | Fluence Energy, Inc. | 6.7 mo | medium | $387.30M | $57.98M | 6mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| BEAM | Beam Therapeutics Inc. | 6.7 mo | medium | $288.29M | $42.84M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| LION | Lionsgate Studios Corp. | 6.7 mo | medium | $182.40M | $27.10M | 9mo · Dec 31, 2025 | 10-Q · Feb 5, 2026 | view |
| SANA | Sana Biotechnology, Inc. | 6.7 mo | medium | $83.80M | $12.46M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| MBX | MBX Biosciences, Inc. | 6.7 mo | medium | $45.21M | $6.74M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| VRCA | Verrica Pharmaceuticals Inc. | 6.7 mo | medium | $20.60M | $3.05M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| SAFE | Safehold Inc. | 6.7 mo | medium | $19.30M | $2.87M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| SEV | Aptera Motors Corp | 6.7 mo | medium | $17.72M | $2.63M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| LPCN | Lipocine Inc. | 6.7 mo | medium | $5.02M | $752.4K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| FJET | Starfighters Space, Inc. | 6.7 mo | medium | $4.58M | $685.6K | 12mo · Dec 31, 2025 | 10-K · Apr 15, 2026 | view |
| IQST | iQSTEL Inc | 6.7 mo | medium | $2.16M | $320.4K | 12mo · Dec 31, 2025 | 10-K · Apr 6, 2026 | view |
| SCKT | SOCKET MOBILE, INC. | 6.7 mo | medium | $1.71M | $256.3K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| CVR | CHICAGO RIVET & MACHINE CO | 6.7 mo | medium | $1.45M | $216.5K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| BAOS | Baosheng Media Group Holdings Ltd | 6.7 mo | medium | $1.27M | $188.4K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| AMST | Amesite Inc. | 6.7 mo | medium | $1.17M | $172.8K | 6mo · Dec 31, 2025 | 10-Q · Feb 6, 2026 | view |
| OCEA | Ocean Biomedical, Inc. | 6.7 mo | medium | $800.0K | $118.7K | 3mo · Mar 31, 2025 | 10-Q · May 15, 2025 | view |
| AIBT | AIBOTICS, INC. | 6.7 mo | medium | $255.9K | $38.2K | 12mo · Dec 31, 2025 | 10-K · Apr 15, 2026 | view |
| YTFD | Yale Transaction Finders, Inc. | 6.7 mo | medium | $17.4K | $2.6K | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| NTCS | Natics Corp. | 6.7 mo | medium | $5.7K | $848 | 9mo · Jan 31, 2026 | 10-Q · Feb 17, 2026 | view |
| PSX | Phillips 66 | 6.8 mo | medium | $5.15B | $754.67M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| FGNX | FG Nexus Inc. | 6.8 mo | medium | $14.14M | $2.08M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ICU | SeaStar Medical Holding Corp | 6.8 mo | medium | $6.30M | $920.3K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| LZMH | LZ Technology Holdings Ltd | 6.8 mo | medium | $3.36M | $490.9K | 12mo · Dec 31, 2025 | 20-F · Apr 28, 2026 | view |
| AUUD | AUDDIA INC. | 6.8 mo | medium | $3.19M | $469.4K | 12mo · Dec 31, 2025 | 10-K · Mar 6, 2026 | view |
| SNOA | Sonoma Pharmaceuticals, Inc. | 6.8 mo | medium | $2.56M | $379.3K | 9mo · Dec 31, 2025 | 10-Q · Feb 10, 2026 | view |
| SRPT | Sarepta Therapeutics, Inc. | 6.9 mo | medium | $464.45M | $67.56M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| ABCL | AbCellera Biologics Inc. | 6.9 mo | medium | $77.06M | $11.17M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| JBIO | Jade Biosciences, Inc. | 6.9 mo | medium | $55.09M | $8.03M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| PEPG | PepGen Inc. | 6.9 mo | medium | $42.15M | $6.14M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| NIPG | NIP Group Inc. | 6.9 mo | medium | $9.56M | $1.38M | 12mo · Dec 31, 2024 | 20-F · May 12, 2025 | view |
| INDP | Indaptus Therapeutics, Inc. | 6.9 mo | medium | $8.51M | $1.24M | 12mo · Dec 31, 2025 | 10-K · Mar 17, 2026 | view |
| TGL | TREASURE GLOBAL INC | 6.9 mo | medium | $5.45M | $788.6K | 6mo · Dec 31, 2025 | 10-Q · Feb 23, 2026 | view |
| BQ | Boqii Holding Ltd | 6.9 mo | medium | $5.33M | $767.5K | 12mo · Mar 31, 2025 | 20-F/A · Mar 19, 2026 | view |
| ENVB | Enveric Biosciences, Inc. | 6.9 mo | medium | $4.68M | $678.5K | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| IHT | INNSUITES HOSPITALITY TRUST | 6.9 mo | medium | $14.0K | $2.0K | 9mo · Oct 31, 2025 | 10-Q · Dec 15, 2025 | view |
| MRSH | MARSH & MCLENNAN COMPANIES, INC. | 7.0 mo | medium | $1.61B | $229.33M | 3mo · Mar 31, 2026 | 10-Q · Apr 16, 2026 | view |
| SPCE | Virgin Galactic Holdings, Inc | 7.0 mo | medium | $124.84M | $17.83M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| SNDA | SONIDA SENIOR LIVING, INC. | 7.0 mo | medium | $84.28M | $11.96M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| CBLL | Ceribell, Inc. | 7.0 mo | medium | $45.25M | $6.43M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| ALLO | Allogene Therapeutics, Inc. | 7.0 mo | medium | $30.31M | $4.30M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| BJDX | Bluejay Diagnostics, Inc. | 7.0 mo | medium | $3.68M | $529.7K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| BLDC | Blockfusion Data Centers, Inc. | 7.0 mo | medium | $560.8K | $80.1K | 11mo · Dec 31, 2025 | S-4/A · May 1, 2026 | view |
| LYEL | Lyell Immunopharma, Inc. | 7.1 mo | medium | $90.77M | $12.84M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| SES | SES AI Corp | 7.1 mo | medium | $46.94M | $6.60M | 3mo · Mar 31, 2026 | 10-Q · Apr 24, 2026 | view |
| OM | Outset Medical, Inc. | 7.1 mo | medium | $30.56M | $4.28M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| QNCX | Quince Therapeutics, Inc. | 7.1 mo | medium | $18.16M | $2.54M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | 7.1 mo | medium | $6.86M | $971.7K | 9mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| AEON | AEON Biopharma, Inc. | 7.1 mo | medium | $6.24M | $878.7K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| CLGN | CollPlant Biotechnologies Ltd | 7.1 mo | medium | $5.59M | $784.9K | 12mo · Dec 31, 2025 | 20-F · Mar 26, 2026 | view |
| OLOX | OLENOX INDUSTRIES INC. | 7.1 mo | medium | $3.02M | $424.2K | 9mo · Sep 30, 2025 | 10-Q · Nov 14, 2025 | view |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | 7.1 mo | medium | $155.8K | $21.8K | 12mo · Dec 31, 2025 | 10-K · Apr 16, 2026 | view |
| UCLE | US NUCLEAR CORP. | 7.1 mo | medium | $75.9K | $10.7K | 9mo · Sep 30, 2025 | 10-Q · Jan 27, 2026 | view |
| HGYN | HONG YUAN HOLDING GROUP | 7.1 mo | medium | $16.7K | $2.4K | 12mo · Dec 31, 2025 | 10-K · May 8, 2026 | view |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 7.2 mo | medium | $712.00M | $99.00M | 3mo · Mar 31, 2026 | 10-Q · Apr 22, 2026 | view |
| WEST | Westrock Coffee Co | 7.2 mo | medium | $28.11M | $3.92M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| FRSX | Foresight Autonomous Holdings Ltd. | 7.2 mo | medium | $6.24M | $871.1K | 12mo · Dec 31, 2025 | 20-F · Mar 25, 2026 | view |
| MKZR | MacKenzie Realty Capital, Inc. | 7.2 mo | medium | $4.34M | $598.1K | 6mo · Dec 31, 2025 | 10-Q · Feb 17, 2026 | view |
| NEPH | NEPHROS INC | 7.2 mo | medium | $4.02M | $557.0K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| CYCN | Cyclerion Therapeutics, Inc. | 7.2 mo | medium | $2.82M | $392.0K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| QS | QuantumScape Corp | 7.3 mo | medium | $145.07M | $19.84M | 3mo · Mar 31, 2026 | 10-Q · Apr 24, 2026 | view |
| URGN | UroGen Pharma Ltd. | 7.3 mo | medium | $109.97M | $15.11M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| GPRE | Green Plains Inc. | 7.3 mo | medium | $95.72M | $13.17M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| PTHS | Pelthos Therapeutics Inc. | 7.3 mo | medium | $31.98M | $4.38M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| PSQH | PSQ Holdings, Inc. | 7.3 mo | medium | $10.06M | $1.38M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ICCM | IceCure Medical Ltd. | 7.3 mo | medium | $8.90M | $1.21M | 12mo · Dec 31, 2025 | 20-F · Mar 17, 2026 | view |
| CWK | Cushman & Wakefield Ltd. | 7.4 mo | medium | $600.60M | $81.17M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| OTF | Blue Owl Technology Finance Corp. | 7.4 mo | medium | $488.16M | $65.75M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| RHI | ROBERT HALF INC. | 7.4 mo | medium | $278.39M | $37.45M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| TEAD | Teads Holding Co. | 7.4 mo | medium | $85.49M | $11.62M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| TBI | TrueBlue, Inc. | 7.4 mo | medium | $24.13M | $3.26M | 3mo · Mar 29, 2026 | 10-Q · May 5, 2026 | view |
| PAVM | PAVmed Inc. | 7.4 mo | medium | $6.46M | $873.3K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| CANF | Can-Fite BioPharma Ltd. | 7.4 mo | medium | $5.53M | $745.8K | 12mo · Dec 31, 2025 | 20-F · Mar 26, 2026 | view |
| VRDR | VERDE RESOURCES, INC. | 7.4 mo | medium | $2.13M | $289.2K | 9mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ARMK | Aramark | 7.5 mo | medium | $475.72M | $63.66M | 6mo · Apr 3, 2026 | 10-Q · May 12, 2026 | view |
| HY | HYSTER-YALE, INC. | 7.5 mo | medium | $81.80M | $10.97M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| BDSX | BIODESIX INC | 7.5 mo | medium | $25.57M | $3.39M | 3mo · Mar 31, 2026 | 10-Q · May 4, 2026 | view |
| DRIO | DarioHealth Corp. | 7.5 mo | medium | $14.98M | $2.01M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| NPCE | NeuroPace Inc | 7.5 mo | medium | $14.78M | $1.97M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| SPWR | SunPower Inc. | 7.5 mo | medium | $9.62M | $1.28M | 12mo · Dec 28, 2025 | 10-K · Apr 14, 2026 | view |
| DTST | Data Storage Corp | 7.5 mo | medium | $1.99M | $263.5K | 12mo · Dec 31, 2025 | 10-K · Apr 14, 2026 | view |
| CMT | CORE MOLDING TECHNOLOGIES INC | 7.6 mo | medium | $23.51M | $3.08M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| HOTH | Hoth Therapeutics, Inc. | 7.6 mo | medium | $6.25M | $817.0K | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| GLMD | Galmed Pharmaceuticals Ltd. | 7.6 mo | medium | $3.98M | $526.3K | 12mo · Dec 31, 2025 | 20-F · Mar 31, 2026 | view |
| HTCR | HeartCore Enterprises, Inc. | 7.6 mo | medium | $1.99M | $259.8K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| GKOR | Golkor Inc. | 7.6 mo | medium | $186.2K | $24.5K | 9mo · Aug 31, 2025 | 10-Q · Oct 17, 2025 | view |
| FTAI | FTAI Aviation Ltd. | 7.7 mo | medium | $412.24M | $53.36M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| STOK | Stoke Therapeutics, Inc. | 7.7 mo | medium | $155.66M | $20.19M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| SMHI | SEACOR Marine Holdings Inc. | 7.7 mo | medium | $38.72M | $5.04M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| PASG | Passage BIO, Inc. | 7.7 mo | medium | $33.34M | $4.33M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| PCOK | Pacific Oak Strategic Opportunity REIT, Inc. | 7.7 mo | medium | $19.99M | $2.59M | 9mo · Sep 30, 2025 | 10-Q · Nov 14, 2025 | view |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | 7.7 mo | medium | $20.03M | $2.59M | 12mo · Dec 31, 2025 | 10-K · Mar 12, 2026 | view |
| SNGX | SOLIGENIX, INC. | 7.7 mo | medium | $6.03M | $785.9K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| KARX | Karbon-X Corp. | 7.7 mo | medium | $4.06M | $523.6K | 9mo · Feb 28, 2026 | 10-Q · Apr 20, 2026 | view |
| UOKA | MDJM LTD | 7.7 mo | medium | $700.5K | $90.6K | 12mo · Dec 31, 2025 | 20-F · Apr 1, 2026 | view |
| HCIL | Hongchang International Co., Ltd | 7.7 mo | medium | $551.8K | $71.3K | 9mo · Dec 31, 2025 | 10-Q · Feb 13, 2026 | view |
| INSM | INSMED Inc | 7.8 mo | medium | $582.19M | $74.25M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| NPWR | NET Power Inc. | 7.8 mo | medium | $133.15M | $17.03M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| SNDX | Syndax Pharmaceuticals Inc | 7.8 mo | medium | $130.89M | $16.78M | 3mo · Mar 31, 2026 | 10-Q · Apr 30, 2026 | view |
| TYRA | Tyra Biosciences, Inc. | 7.8 mo | medium | $84.95M | $10.86M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| DSGR | Distribution Solutions Group, Inc. | 7.8 mo | medium | $52.73M | $6.79M | 3mo · Mar 31, 2026 | 10-Q · Apr 30, 2026 | view |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 7.8 mo | medium | $38.09M | $4.91M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| FWDI | Forward Industries, Inc. | 7.8 mo | medium | $16.63M | $2.12M | 6mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| SBLX | StableX Technologies, Inc. | 7.8 mo | medium | $4.98M | $641.3K | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| ORKT | ORANGEKLOUD TECHNOLOGY INC. | 7.8 mo | medium | $2.32M | $296.0K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| AMC | AMC ENTERTAINMENT HOLDINGS, INC. | 7.9 mo | medium | $339.20M | $42.83M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| CELC | Celcuity Inc. | 7.9 mo | medium | $145.19M | $18.36M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| TNC | TENNANT CO | 7.9 mo | medium | $82.60M | $10.40M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| BZAI | Blaize Holdings, Inc. | 7.9 mo | medium | $33.22M | $4.21M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| CBUS | Cibus, Inc. | 7.9 mo | medium | $30.32M | $3.83M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| BIVI | BIOVIE INC. | 7.9 mo | medium | $13.10M | $1.66M | 9mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| COEP | Coeptis Therapeutics Holdings, Inc. | 7.9 mo | medium | $5.67M | $716.9K | 12mo · Dec 31, 2025 | 10-K · Mar 19, 2026 | view |
| CTA-PB | EIDP, Inc. | 8.0 mo | medium | $3.80B | $474.00M | 3mo · Mar 31, 2019 | 10-Q · May 8, 2019 | view |
| CNXC | Concentrix Corp | 8.0 mo | medium | $222.70M | $27.74M | 3mo · Feb 28, 2026 | 10-Q · Apr 3, 2026 | view |
| ESI | Element Solutions Inc | 8.0 mo | medium | $177.30M | $22.20M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| FULC | Fulcrum Therapeutics, Inc. | 8.0 mo | medium | $50.26M | $6.25M | 3mo · Mar 31, 2026 | 10-Q · Apr 27, 2026 | view |
| PATK | PATRICK INDUSTRIES INC | 8.0 mo | medium | $37.47M | $4.67M | 3mo · Mar 29, 2026 | 10-Q · May 7, 2026 | view |
| KYNB | KYNTRA BIO, INC. | 8.0 mo | medium | $37.00M | $4.63M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| LSF | Laird Superfood, Inc. | 8.0 mo | medium | $10.25M | $1.28M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| RVYL | RYVYL Inc. | 8.0 mo | medium | $5.51M | $688.3K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| NIXX | Nixxy, Inc. | 8.0 mo | medium | $1.03M | $128.3K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ENVX | Enovix Corp | 8.1 mo | medium | $88.75M | $11.02M | 3mo · Apr 5, 2026 | 10-Q · May 14, 2026 | view |
| KSCP | Knightscope, Inc. | 8.1 mo | medium | $20.57M | $2.53M | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| DCOY | Decoy Therapeutics Inc. | 8.1 mo | medium | $7.82M | $963.1K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| IPWR | Ideal Power Inc. | 8.1 mo | medium | $6.13M | $761.3K | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| BDCI | BTC Development Corp. | 8.1 mo | medium | $1.45M | $179.1K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| GIW | GigCapital8 Corp. | 8.1 mo | medium | $1.05M | $130.3K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| APYP | APPYEA, INC | 8.1 mo | medium | $408.0K | $50.5K | 12mo · Dec 31, 2025 | 10-K · Apr 16, 2026 | view |
| CRDV | Community Redevelopment Inc. | 8.1 mo | medium | $118.2K | $14.6K | 9mo · Sep 30, 2023 | 10-Q/A · Nov 21, 2023 | view |
| IBRX | ImmunityBio, Inc. | 8.2 mo | medium | $205.19M | $25.12M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | 8.2 mo | medium | $196.51M | $24.02M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| CABA | Cabaletta Bio, Inc. | 8.2 mo | medium | $116.64M | $14.19M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| ATRA | Atara Biotherapeutics, Inc. | 8.2 mo | medium | $8.36M | $1.02M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| CMMB | Chemomab Therapeutics Ltd. | 8.2 mo | medium | $7.56M | $927.5K | 12mo · Dec 31, 2025 | 20-F · Mar 23, 2026 | view |
| DSS | DSS, INC. | 8.2 mo | medium | $6.21M | $760.8K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| INM | InMed Pharmaceuticals Inc. | 8.2 mo | medium | $5.16M | $631.0K | 9mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| TJGC | TJGC GROUP Ltd | 8.2 mo | medium | $3.07M | $373.1K | 12mo · Mar 31, 2025 | 20-F · Aug 15, 2025 | view |
| XTKG | X3 Holdings Co., Ltd. | 8.2 mo | medium | $2.21M | $270.1K | 12mo · Dec 31, 2025 | 20-F · Apr 27, 2026 | view |
| CVSI | CV Sciences, Inc. | 8.2 mo | medium | $278.0K | $33.9K | 12mo · Dec 31, 2025 | 10-K · Mar 26, 2026 | view |
| COGT | Cogent Biosciences, Inc. | 8.3 mo | medium | $241.21M | $28.96M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 8.3 mo | medium | $171.59M | $20.60M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| CDXS | CODEXIS, INC. | 8.3 mo | medium | $36.57M | $4.38M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| OGEN | ORAGENICS INC | 8.3 mo | medium | $6.11M | $733.5K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| SUIG | SUI Group Holdings Ltd. | 8.3 mo | medium | $5.01M | $599.9K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| SEED | Origin Agritech LTD | 8.3 mo | medium | $2.23M | $268.0K | 12mo · Sep 30, 2025 | 20-F · Jan 30, 2026 | view |
| SEPN | Septerna, Inc. | 8.4 mo | medium | $71.61M | $8.54M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| GUTS | FRACTYL HEALTH, INC. | 8.4 mo | medium | $63.17M | $7.49M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| PTN | PALATIN TECHNOLOGIES INC | 8.4 mo | medium | $10.16M | $1.20M | 9mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| DRMA | Dermata Therapeutics, Inc. | 8.4 mo | medium | $6.95M | $826.6K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ULY | Urgent.ly Inc. | 8.4 mo | medium | $5.16M | $613.6K | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| MINR | Minerva Gold Inc. | 8.4 mo | medium | $7.1K | $842 | 12mo · Feb 28, 2026 | 10-K · May 11, 2026 | view |
| AURA | Aura Biosciences, Inc. | 8.5 mo | medium | $84.79M | $9.96M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| GLOO | Gloo Holdings, Inc. | 8.5 mo | medium | $57.31M | $6.71M | 12mo · Jan 31, 2026 | 10-K · Apr 15, 2026 | view |
| VTGN | Vistagen Therapeutics, Inc. | 8.5 mo | medium | $47.37M | $5.58M | 9mo · Dec 31, 2025 | 10-Q · Feb 12, 2026 | view |
| OXSQ | Oxford Square Capital Corp. | 8.5 mo | medium | $40.92M | $4.80M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| SXT | SENSIENT TECHNOLOGIES CORP | 8.5 mo | medium | $38.54M | $4.54M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| LITS | Lite Strategy, Inc. | 8.5 mo | medium | $7.54M | $884.1K | 9mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ZEO | Zeo Energy Corp. | 8.5 mo | medium | $6.14M | $724.3K | 12mo · Dec 31, 2025 | 10-K · Apr 1, 2026 | view |
| NNVC | NANOVIRICIDES, INC. | 8.5 mo | medium | $5.15M | $607.3K | 6mo · Dec 31, 2025 | 10-Q · Feb 17, 2026 | view |
| ADIL | ADIAL PHARMACEUTICALS, INC. | 8.5 mo | medium | $4.58M | $537.5K | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| LGMK | LogicMark, Inc. | 8.5 mo | medium | $3.57M | $421.7K | 12mo · Dec 31, 2025 | 10-K · Mar 27, 2026 | view |
| WAST | WASTE ENERGY CORP. | 8.5 mo | medium | $47.4K | $5.6K | 9mo · Sep 30, 2025 | 10-Q · Nov 13, 2025 | view |
| MLYS | Mineralys Therapeutics, Inc. | 8.6 mo | medium | $112.78M | $13.16M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| CSTL | CASTLE BIOSCIENCES INC | 8.6 mo | medium | $63.76M | $7.38M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| CNTB | Connect Biopharma Holdings Ltd | 8.6 mo | medium | $46.03M | $5.33M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| WGS | GeneDx Holdings Corp. | 8.7 mo | medium | $93.92M | $10.80M | 3mo · Mar 31, 2026 | 10-Q · May 4, 2026 | view |
| SION | Sionna Therapeutics, Inc. | 8.7 mo | medium | $63.32M | $7.28M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| VYNE | VYNE Therapeutics Inc. | 8.7 mo | medium | $24.03M | $2.76M | 12mo · Dec 31, 2025 | S-4/A · Apr 28, 2026 | view |
| CMBM | Cambium Networks Corp | 8.7 mo | medium | $11.33M | $1.31M | 12mo · Dec 31, 2025 | 10-K · May 1, 2026 | view |
| AIMD | Ainos, Inc. | 8.7 mo | medium | $2.84M | $327.8K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| CRSF | Crisp Momentum Inc. | 8.7 mo | medium | $2.11M | $243.7K | 3mo · Oct 31, 2025 | 10-Q/A · Feb 17, 2026 | view |
| NEWH | NewHydrogen, Inc. | 8.7 mo | medium | $1.44M | $166.1K | 12mo · Dec 31, 2025 | POS AM · Apr 24, 2026 | view |
| PRIM | Primoris Services Corp | 8.8 mo | medium | $361.50M | $40.87M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| FRST | Primis Financial Corp. | 8.8 mo | medium | $159.88M | $18.12M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| CMLS | CUMULUS MEDIA INC | 8.8 mo | medium | $57.61M | $6.52M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| BDTX | Black Diamond Therapeutics, Inc. | 8.8 mo | medium | $30.07M | $3.41M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ABUS | Arbutus Biopharma Corp | 8.8 mo | medium | $23.71M | $2.70M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| LNSR | LENSAR, Inc. | 8.8 mo | medium | $12.49M | $1.42M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| MPU | Mega Matrix Inc | 8.8 mo | medium | $7.30M | $825.5K | 12mo · Dec 31, 2025 | 20-F · Apr 16, 2026 | view |
| BGMS | Bio Green Med Solution, Inc. | 8.8 mo | medium | $3.50M | $397.5K | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| INTI | Inhibitor Therapeutics, Inc. | 8.8 mo | medium | $2.38M | $269.3K | 12mo · Dec 31, 2025 | 10-K · Mar 26, 2026 | view |
| BRQSF | Borqs Technologies, Inc. | 8.8 mo | medium | $2.03M | $230.8K | 12mo · Dec 31, 2024 | 20-F · May 15, 2025 | view |
| SRGZ | Star Gold Corp. | 8.8 mo | medium | $266.1K | $30.1K | 9mo · Jan 31, 2026 | 10-Q · Mar 16, 2026 | view |
| SOLV | Solventum Corp | 8.9 mo | medium | $561.00M | $63.00M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| CALY | Callaway Golf Co | 8.9 mo | medium | $499.50M | $56.33M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| DNLI | Denali Therapeutics Inc. | 8.9 mo | medium | $387.63M | $43.73M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| CODQL | Coronado Global Resources Inc. | 8.9 mo | medium | $121.04M | $13.65M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| RGTI | Rigetti Computing, Inc. | 8.9 mo | medium | $48.15M | $5.41M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| KLRS | Kalaris Therapeutics, Inc. | 8.9 mo | medium | $34.43M | $3.86M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| BARK | Bark, Inc. | 8.9 mo | medium | $21.68M | $2.42M | 9mo · Dec 31, 2025 | 10-Q · Feb 5, 2026 | view |
| CV | CapsoVision, Inc | 8.9 mo | medium | $17.93M | $2.02M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| GALT | GALECTIN THERAPEUTICS INC | 8.9 mo | medium | $17.72M | $1.99M | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| FTCO | Fortitude Gold Corp | 8.9 mo | medium | $10.03M | $1.13M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| NTRP | NextTrip, Inc. | 8.9 mo | medium | $2.43M | $272.3K | 9mo · Nov 30, 2025 | 10-Q · Jan 14, 2026 | view |
| THMG | THUNDER MOUNTAIN GOLD INC | 8.9 mo | medium | $1.81M | $202.6K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| VBIX | Viewbix Inc. | 8.9 mo | medium | $1.79M | $201.3K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| VFF | Village Farms International, Inc. | 9.0 mo | medium | $50.47M | $5.59M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| TTI | TETRA TECHNOLOGIES INC | 9.0 mo | medium | $35.47M | $3.95M | 3mo · Mar 31, 2026 | 10-Q · Apr 29, 2026 | view |
| RXO | RXO, Inc. | 9.0 mo | medium | $21.00M | $2.33M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| CDZI | CADIZ INC | 9.0 mo | medium | $16.54M | $1.84M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| GRI | GRI Bio, Inc. | 9.0 mo | medium | $11.05M | $1.23M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| TGEN | TECOGEN INC. | 9.0 mo | medium | $9.33M | $1.04M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| BFRG | BullFrog AI Holdings, Inc. | 9.0 mo | medium | $5.08M | $564.7K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| PULM | Pulmatrix, Inc. | 9.0 mo | medium | $4.09M | $452.8K | 12mo · Dec 31, 2025 | 10-K · Feb 26, 2026 | view |
| TWAV | TaoWeave, Inc. | 9.0 mo | medium | $2.26M | $251.3K | 12mo · Dec 31, 2025 | 10-K · Mar 20, 2026 | view |
| MCOM | micromobility.com Inc. | 9.0 mo | medium | $15.0K | $1.7K | 9mo · Sep 30, 2025 | 10-Q · Nov 12, 2025 | view |
| MRNA | Moderna, Inc. | 9.1 mo | medium | $1.91B | $210.00M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| REZI | RESIDEO TECHNOLOGIES, INC. | 9.1 mo | medium | $438.00M | $48.33M | 3mo · Apr 4, 2026 | 10-Q · May 12, 2026 | view |
| CWH | Camping World Holdings, Inc. | 9.1 mo | medium | $199.83M | $21.86M | 3mo · Mar 31, 2026 | 10-Q · Apr 30, 2026 | view |
| COSO | CoastalSouth Bancshares, Inc. | 9.1 mo | medium | $62.56M | $6.87M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| NN | NEXTNAV INC. | 9.1 mo | medium | $30.60M | $3.35M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| ANVS | Annovis Bio, Inc. | 9.1 mo | medium | $19.53M | $2.13M | 12mo · Dec 31, 2025 | 10-K · Mar 13, 2026 | view |
| LVO | LiveOne, Inc. | 9.1 mo | medium | $8.62M | $946.2K | 9mo · Dec 31, 2025 | 10-Q · Feb 13, 2026 | view |
| NXTS | Nexentis Technologies Inc. | 9.1 mo | medium | $4.30M | $473.0K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| BMTM | Bright Mountain Media, Inc. | 9.1 mo | medium | $594.0K | $65.3K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| COMP | Compass, Inc. | 9.2 mo | medium | $484.00M | $52.33M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| THO | THOR INDUSTRIES INC | 9.2 mo | medium | $242.18M | $26.18M | 6mo · Jan 31, 2026 | 10-Q · Mar 3, 2026 | view |
| DNA | Ginkgo Bioworks Holdings, Inc. | 9.2 mo | medium | $143.86M | $15.56M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ASST | Strive, Inc. | 9.2 mo | medium | $95.09M | $10.33M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| RBBN | Ribbon Communications Inc. | 9.2 mo | medium | $67.55M | $7.33M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| SEER | Seer, Inc. | 9.2 mo | medium | $47.32M | $5.14M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| PRHI | Presurance Holdings, Inc. | 9.2 mo | medium | $25.47M | $2.77M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ATOM | Atomera Inc | 9.2 mo | medium | $14.16M | $1.54M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| XXII | 22nd Century Group, Inc. | 9.2 mo | medium | $9.54M | $1.03M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| HUDI | Huadi International Group Co., Ltd. | 9.2 mo | medium | $6.48M | $706.7K | 12mo · Sep 30, 2025 | 20-F · Jan 30, 2026 | view |
| DLPN | Dolphin Entertainment, Inc. | 9.2 mo | medium | $6.28M | $680.6K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| FUSE | Fusemachines Inc. | 9.2 mo | medium | $4.22M | $460.8K | 12mo · Dec 31, 2025 | S-1/A · Apr 27, 2026 | view |
| JACS | Jackson Acquisition Co II | 9.2 mo | medium | $393.5K | $42.8K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| HGAS | Global Gas Corp | 9.2 mo | medium | $48.7K | $5.3K | 12mo · Dec 31, 2025 | 10-K · Apr 15, 2026 | view |
| NX | Quanex Building Products CORP | 9.3 mo | medium | $62.31M | $6.74M | 3mo · Jan 31, 2026 | 10-Q · Mar 6, 2026 | view |
| ABEO | ABEONA THERAPEUTICS INC. | 9.3 mo | medium | $61.37M | $6.60M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| FBRX | Forte Biosciences, Inc. | 9.3 mo | medium | $58.22M | $6.27M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| BRLT | Brilliant Earth Group, Inc. | 9.3 mo | medium | $58.56M | $6.26M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| AIRO | AIRO Group Holdings, Inc. | 9.3 mo | medium | $54.23M | $5.80M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| SKYH | Sky Harbour Group Corp | 9.3 mo | medium | $12.10M | $1.31M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| HIT | Health In Tech, Inc. | 9.3 mo | medium | $10.33M | $1.11M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| RGC | Regencell Bioscience Holdings Ltd | 9.3 mo | medium | $2.42M | $259.5K | 12mo · Jun 30, 2025 | 20-F · Oct 31, 2025 | view |
| ESLA | Estrella Immunopharma, Inc. | 9.3 mo | medium | $1.38M | $148.8K | 12mo · Dec 31, 2025 | 10-K · Mar 18, 2026 | view |
| PRGO | PERRIGO Co plc | 9.4 mo | medium | $357.20M | $37.87M | 3mo · Mar 28, 2026 | 10-Q · May 6, 2026 | view |
| AAWH | Ascend Wellness Holdings, Inc. | 9.4 mo | medium | $60.92M | $6.47M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ADGM | Adagio Medical Holdings, Inc. | 9.4 mo | medium | $12.91M | $1.38M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| MDAI | Spectral AI, Inc. | 9.4 mo | medium | $11.70M | $1.24M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| TELO | Telomir Pharmaceuticals, Inc. | 9.4 mo | medium | $5.56M | $591.2K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| FACT | FACT II Acquisition Corp. | 9.4 mo | medium | $412.9K | $44.0K | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| VSTM | Verastem, Inc. | 9.5 mo | medium | $165.55M | $17.37M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| NMRA | Neumora Therapeutics, Inc. | 9.5 mo | medium | $147.07M | $15.47M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| YXT | YXT.COM GROUP HOLDING Ltd | 9.5 mo | medium | $16.44M | $1.74M | 12mo · Dec 31, 2025 | 20-F · Apr 29, 2026 | view |
| LAKE | LAKELAND INDUSTRIES INC | 9.5 mo | medium | $12.52M | $1.31M | 12mo · Jan 31, 2026 | 10-K · Apr 16, 2026 | view |
| AMIX | Autonomix Medical, Inc. | 9.5 mo | medium | $9.93M | $1.04M | 9mo · Dec 31, 2025 | 10-Q · Feb 11, 2026 | view |
| SSGC | SafeSpace Global Corp | 9.5 mo | medium | $3.86M | $407.8K | 6mo · Jan 31, 2026 | 10-Q · Mar 17, 2026 | view |
| PRFX | PRF Technologies Ltd. | 9.5 mo | medium | $3.13M | $329.6K | 12mo · Dec 31, 2025 | 20-F · Mar 26, 2026 | view |
| NCEL | NewcelX Ltd. | 9.5 mo | medium | $2.20M | $230.5K | 12mo · Dec 31, 2025 | 20-F · Apr 29, 2026 | view |
| BGI | BIRKS GROUP INC. | 9.5 mo | medium | $1.51M | $159.3K | 12mo · Mar 29, 2025 | 20-F · Jul 25, 2025 | view |
| CMPX | Compass Therapeutics, Inc. | 9.6 mo | medium | $55.17M | $5.76M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| VANI | Vivani Medical, Inc. | 9.6 mo | medium | $19.75M | $2.07M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| OZ | Belpointe PREP, LLC | 9.6 mo | medium | $19.57M | $2.04M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| VISL | Vislink Technologies, Inc. | 9.6 mo | medium | $5.50M | $570.2K | 12mo · Dec 31, 2024 | 10-K · May 2, 2025 | view |
| SAFT | SAFETY INSURANCE GROUP INC | 9.7 mo | medium | $54.83M | $5.68M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| ELUT | ELUTIA INC. | 9.7 mo | medium | $36.35M | $3.73M | 12mo · Dec 31, 2025 | 10-K · Mar 13, 2026 | view |
| ATLX | Atlas Lithium Corp | 9.7 mo | medium | $34.36M | $3.54M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| MTVA | MetaVia Inc. | 9.7 mo | medium | $13.73M | $1.42M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| TCI | TRANSCONTINENTAL REALTY INVESTORS INC | 9.7 mo | medium | $9.47M | $979.3K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| LEXX | Lexaria Bioscience Corp. | 9.7 mo | medium | $5.10M | $524.7K | 6mo · Feb 28, 2026 | 10-Q · Apr 13, 2026 | view |
| AIRI | AIR INDUSTRIES GROUP | 9.7 mo | medium | $4.22M | $432.7K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| JBDI | JBDI Holdings Ltd | 9.7 mo | medium | $2.73M | $280.6K | 12mo · May 31, 2025 | 20-F · Oct 14, 2025 | view |
| SN | SharkNinja, Inc. | 9.8 mo | medium | $511.77M | $52.09M | 3mo · Mar 31, 2026 | 10-Q · May 6, 2026 | view |
| IONQ | IonQ, Inc. | 9.8 mo | medium | $493.54M | $50.34M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| WKC | WORLD KINECT CORP | 9.8 mo | medium | $151.10M | $15.47M | 3mo · Mar 31, 2026 | 10-Q · Apr 24, 2026 | view |
| PSNL | Personalis, Inc. | 9.8 mo | medium | $73.59M | $7.49M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| REKR | Rekor Systems, Inc. | 9.8 mo | medium | $12.18M | $1.25M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| AIIO | ROBO.AI INC. | 9.8 mo | medium | $4.14M | $422.2K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| JZ | Jianzhi Education Technology Group Co Ltd | 9.8 mo | medium | $1.17M | $119.1K | 12mo · Dec 31, 2025 | 20-F · Apr 13, 2026 | view |
| ZICX | Zicix Corp | 9.8 mo | medium | $20.9K | $2.1K | 9mo · Dec 31, 2025 | 10-Q · Feb 20, 2026 | view |
| AARD | Aardvark Therapeutics, Inc. | 9.9 mo | medium | $62.44M | $6.29M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| ATOS | ATOSSA THERAPEUTICS, INC. | 9.9 mo | medium | $31.72M | $3.19M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| AAMI | Acadian Asset Management Inc. | 10.0 mo | medium | $150.00M | $14.97M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| RNXT | RenovoRx, Inc. | 10.0 mo | medium | $12.36M | $1.24M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| SBFM | Sunshine Biopharma Inc. | 10.0 mo | medium | $6.91M | $690.7K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| TAOP | Taoping Inc. | 10.0 mo | medium | $2.13M | $212.6K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| EPSM | Epsium Enterprise Ltd | 10.0 mo | medium | $1.98M | $198.3K | 12mo · Dec 31, 2025 | 20-F · Apr 29, 2026 | view |
| APXT | Apex Treasury Corp | 10.0 mo | medium | $762.2K | $76.4K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| CAPC | CAPSTONE COMPANIES, INC. | 10.0 mo | medium | $257.0K | $25.7K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| NKTR | NEKTAR THERAPEUTICS | 10.1 mo | medium | $149.58M | $14.77M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| FOXF | FOX FACTORY HOLDING CORP | 10.1 mo | medium | $53.91M | $5.35M | 3mo · Apr 3, 2026 | 10-Q · May 8, 2026 | view |
| DARE | Dare Bioscience, Inc. | 10.1 mo | medium | $18.52M | $1.84M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| AKA | A.K.A. BRANDS HOLDING CORP. | 10.1 mo | medium | $12.86M | $1.28M | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| FKWL | FRANKLIN WIRELESS CORP | 10.1 mo | medium | $9.36M | $929.1K | 6mo · Dec 31, 2025 | 10-Q · Feb 17, 2026 | view |
| TPTA | Terra Property Trust, Inc. | 10.1 mo | medium | $4.97M | $492.4K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| RMCO | Royalty Management Holding Corp | 10.1 mo | medium | $343.9K | $34.0K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| CAEP | Cantor Equity Partners III, Inc. | 10.1 mo | medium | $25.0K | $2.5K | 12mo · Dec 31, 2025 | 10-K · Mar 16, 2026 | view |
| LXEO | Lexeo Therapeutics, Inc. | 10.2 mo | medium | $71.77M | $7.05M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| PETS | PETMED EXPRESS INC | 10.2 mo | medium | $26.91M | $2.63M | 9mo · Dec 31, 2025 | 10-Q · Feb 5, 2026 | view |
| TVRD | Tvardi Therapeutics, Inc. | 10.2 mo | medium | $19.85M | $1.95M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| CHCI | Comstock Holding Companies, Inc. | 10.2 mo | medium | $19.63M | $1.93M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| VEEE | Twin Vee PowerCats, Co. | 10.2 mo | medium | $5.67M | $553.7K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| BMR | Beamr Imaging Ltd. | 10.2 mo | medium | $3.98M | $391.8K | 12mo · Dec 31, 2025 | 20-F · Feb 26, 2026 | view |
| OILCF | Permex Petroleum Corp | 10.2 mo | medium | $2.09M | $204.6K | 9mo · Jun 30, 2025 | 10-Q · Aug 13, 2025 | view |
| DMII | Drugs Made In America Acquisition II Corp. | 10.2 mo | medium | $347.7K | $34.2K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| EOSE | Eos Energy Enterprises, Inc. | 10.3 mo | medium | $410.66M | $39.91M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| HKHC | Horizon Kinetics Holding Corp | 10.3 mo | medium | $36.88M | $3.59M | 12mo · Dec 31, 2025 | 10-K · Mar 12, 2026 | view |
| COCP | Cocrystal Pharma, Inc. | 10.3 mo | medium | $7.03M | $682.7K | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| YCBD | cbdMD, Inc. | 10.3 mo | medium | $2.64M | $255.8K | 6mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| EVGO | EVgo Inc. | 10.4 mo | medium | $122.44M | $11.79M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| FHTX | Foghorn Therapeutics Inc. | 10.4 mo | medium | $87.66M | $8.42M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| CECO | CECO ENVIRONMENTAL CORP | 10.4 mo | medium | $45.41M | $4.37M | 3mo · Mar 31, 2026 | 10-Q · Apr 30, 2026 | view |
| KPRX | KIORA PHARMACEUTICALS INC | 10.4 mo | medium | $10.96M | $1.05M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| IBATF | INTERNATIONAL BATTERY METALS LTD. | 10.4 mo | medium | $9.13M | $879.8K | 9mo · Dec 31, 2025 | 10-Q · Feb 25, 2026 | view |
| ALTS | ALT5 Sigma Corp | 10.4 mo | medium | $6.22M | $596.4K | 12mo · Dec 27, 2025 | 10-K · Apr 13, 2026 | view |
| GANX | Gain Therapeutics, Inc. | 10.5 mo | medium | $16.54M | $1.58M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| DTCK | DAVIS COMMODITIES Ltd | 10.5 mo | medium | $678.0K | $64.8K | 12mo · Dec 31, 2024 | 20-F · Apr 30, 2025 | view |
| UPST | Upstart Holdings, Inc. | 10.6 mo | medium | $472.93M | $44.43M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| TELA | TELA Bio, Inc. | 10.6 mo | medium | $39.54M | $3.72M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| SNES | SenesTech, Inc. | 10.6 mo | medium | $6.80M | $643.0K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| AMBO | Ambow Education Holding Ltd. | 10.6 mo | medium | $4.20M | $396.3K | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| KAPA | Kairos Pharma, LTD. | 10.6 mo | medium | $3.67M | $345.3K | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| LCCC | Lakeshore Acquisition III Corp. | 10.6 mo | medium | $590.2K | $55.5K | 3mo · Mar 31, 2026 | 10-Q · Apr 23, 2026 | view |
| TNGX | Tango Therapeutics, Inc. | 10.7 mo | medium | $157.83M | $14.79M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| AXTI | AXT INC | 10.7 mo | medium | $41.77M | $3.89M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| NTRB | NutriBand Inc. | 10.7 mo | medium | $4.57M | $427.9K | 12mo · Jan 31, 2026 | 10-K · Apr 29, 2026 | view |
| WW | WW INTERNATIONAL, INC. | 10.8 mo | medium | $120.87M | $11.18M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| PROK | PROKIDNEY CORP. | 10.8 mo | medium | $108.54M | $10.01M | 12mo · Dec 31, 2025 | 10-K · Mar 18, 2026 | view |
| CAPR | CAPRICOR THERAPEUTICS, INC. | 10.8 mo | medium | $105.42M | $9.75M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| AMBR | Amber International Holding Ltd | 10.8 mo | medium | $19.64M | $1.82M | 12mo · Dec 31, 2024 | 20-F · Apr 29, 2025 | view |
| LGVN | Longeveron Inc. | 10.8 mo | medium | $15.76M | $1.46M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| LXFR | LUXFER HOLDINGS PLC | 10.8 mo | medium | $14.80M | $1.37M | 3mo · Mar 29, 2026 | 10-Q · Apr 28, 2026 | view |
| VUZI | Vuzix Corp | 10.9 mo | medium | $20.17M | $1.85M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| YDES | YD Bio Ltd | 10.9 mo | medium | $6.01M | $549.7K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| ELAB | PMGC Holdings Inc. | 10.9 mo | medium | $5.40M | $494.5K | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| MGLD | Marygold Companies, Inc. | 10.9 mo | medium | $2.98M | $272.0K | 9mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| ENRT | Enertopia Corp. | 10.9 mo | medium | $374.4K | $34.3K | 6mo · Feb 28, 2026 | 10-Q · Apr 14, 2026 | view |
| TWI | TITAN INTERNATIONAL INC | 11.0 mo | medium | $171.26M | $15.51M | 3mo · Mar 31, 2026 | 10-Q · Apr 30, 2026 | view |
| QURE | uniQure N.V. | 11.0 mo | medium | $139.99M | $12.75M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| AFCG | Advanced Flower Capital Inc. | 11.0 mo | medium | $112.73M | $10.28M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| PPHC | Public Policy Holding Company, Inc. | 11.0 mo | medium | $42.85M | $3.89M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| VERU | VERU INC. | 11.0 mo | medium | $27.60M | $2.51M | 6mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| RNAZ | Transcode Therapeutics, Inc. | 11.0 mo | medium | $17.81M | $1.63M | 12mo · Dec 31, 2025 | 10-K · Apr 15, 2026 | view |
| TMRC | Texas Mineral Resources Corp. | 11.0 mo | medium | $789.6K | $71.8K | 6mo · Feb 28, 2026 | 10-Q · Apr 14, 2026 | view |
| FITB | FIFTH THIRD BANCORP | 11.1 mo | medium | $4.08B | $368.67M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| ECX | ECARX Holdings Inc. | 11.1 mo | medium | $87.12M | $7.87M | 12mo · Dec 31, 2025 | 20-F · Mar 30, 2026 | view |
| ENTA | ENANTA PHARMACEUTICALS INC | 11.1 mo | medium | $34.93M | $3.14M | 6mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| IMDX | Insight Molecular Diagnostics Inc. | 11.1 mo | medium | $28.20M | $2.55M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| KIDS | ORTHOPEDIATRICS CORP | 11.1 mo | medium | $12.19M | $1.10M | 3mo · Mar 31, 2026 | 10-Q · May 1, 2026 | view |
| CABR | Caring Brands, Inc. | 11.1 mo | medium | $2.03M | $183.6K | 3mo · Mar 31, 2026 | 10-Q · May 12, 2026 | view |
| DUKR | DUKE Robotics Corp. | 11.1 mo | medium | $750.0K | $67.6K | 12mo · Dec 31, 2025 | S-1/A · May 12, 2026 | view |
| ANNX | Annexon, Inc. | 11.2 mo | medium | $175.21M | $15.60M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| FOSL | Fossil Group, Inc. | 11.2 mo | medium | $81.38M | $7.25M | 3mo · Apr 4, 2026 | 10-Q · May 14, 2026 | view |
| GEVO | Gevo, Inc. | 11.2 mo | medium | $78.90M | $7.05M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| PLBY | Playboy, Inc. | 11.2 mo | medium | $30.17M | $2.69M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| CING | Cingulate Inc. | 11.2 mo | medium | $25.89M | $2.30M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| EXDW | Exceed World, Inc. | 11.2 mo | medium | $7.59M | $679.0K | 12mo · Sep 30, 2025 | 10-K · Jan 13, 2026 | view |
| XHG | XChange TEC.INC | 11.2 mo | medium | $1.53M | $136.9K | 12mo · Sep 30, 2025 | 20-F · Jan 14, 2026 | view |
| MTRN | MATERION Corp | 11.3 mo | medium | $16.19M | $1.44M | 3mo · Apr 3, 2026 | 10-Q · Apr 29, 2026 | view |
| AMPG | AmpliTech Group, Inc. | 11.3 mo | medium | $11.81M | $1.05M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| NBY | NovaBay Pharmaceuticals, Inc. | 11.3 mo | medium | $7.96M | $702.5K | 12mo · Dec 31, 2025 | 10-K/A · Apr 29, 2026 | view |
| WFF | WF Holding Ltd | 11.3 mo | medium | $2.30M | $203.1K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| DPLS | DarkPulse, Inc. | 11.3 mo | medium | $62.8K | $5.5K | 12mo · Dec 31, 2025 | POS AM · May 12, 2026 | view |
| BCTX | BriaCell Therapeutics Corp. | 11.4 mo | medium | $29.90M | $2.61M | 6mo · Jan 31, 2026 | 10-Q · Mar 10, 2026 | view |
| CYDY | CytoDyn Inc. | 11.4 mo | medium | $15.65M | $1.37M | 9mo · Feb 28, 2026 | S-1 · Apr 22, 2026 | view |
| HVMC | Highview Merger Corp. | 11.4 mo | medium | $732.5K | $64.3K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| KRRO | Korro Bio, Inc. | 11.5 mo | medium | $61.70M | $5.36M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| BMEA | Biomea Fusion, Inc. | 11.5 mo | medium | $44.69M | $3.89M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| WAMFF | Alaska Silver Corp. | 11.5 mo | medium | $6.43M | $557.9K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| MTUS | Metallus Inc. | 11.6 mo | medium | $104.00M | $8.97M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| CRVS | Corvus Pharmaceuticals, Inc. | 11.6 mo | medium | $40.10M | $3.46M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| LTCH | Latch, Inc. | 11.6 mo | medium | $34.62M | $2.99M | 12mo · Dec 31, 2025 | 10-K · Mar 31, 2026 | view |
| NVCT | Nuvectis Pharma, Inc. | 11.6 mo | medium | $25.13M | $2.17M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| INTT | INTEST CORP | 11.6 mo | medium | $12.87M | $1.10M | 3mo · Mar 31, 2026 | 10-Q · May 11, 2026 | view |
| LINK | INTERLINK ELECTRONICS INC | 11.6 mo | medium | $2.11M | $181.0K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| BIXT | BIOXYTRAN, INC | 11.6 mo | medium | $509.9K | $43.9K | 12mo · Dec 31, 2025 | 10-K · Apr 15, 2026 | view |
| CRSP | CRISPR Therapeutics AG | 11.7 mo | medium | $423.31M | $36.30M | 3mo · Mar 31, 2026 | 10-Q · May 4, 2026 | view |
| YETI | YETI Holdings, Inc. | 11.7 mo | medium | $127.79M | $10.88M | 3mo · Apr 4, 2026 | 10-Q · May 14, 2026 | view |
| XPER | Xperi Inc. | 11.7 mo | medium | $70.42M | $6.00M | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
| LUCD | Lucid Diagnostics Inc. | 11.7 mo | medium | $47.33M | $4.03M | 3mo · Mar 31, 2026 | 10-Q · May 13, 2026 | view |
| ORGN | Origin Materials, Inc. | 11.8 mo | medium | $19.19M | $1.62M | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| WLDS | Wearable Devices Ltd. | 11.8 mo | medium | $6.50M | $549.8K | 12mo · Dec 31, 2025 | 20-F · Mar 12, 2026 | view |
| FBGL | FBS Global Ltd | 11.8 mo | medium | $2.99M | $253.6K | 12mo · Dec 31, 2025 | 20-F · Apr 30, 2026 | view |
| PTGX | Protagonist Therapeutics, Inc | 11.9 mo | medium | $193.71M | $16.31M | 3mo · Mar 31, 2026 | 10-Q · May 5, 2026 | view |
| OLN | OLIN Corp | 11.9 mo | medium | $192.20M | $16.20M | 3mo · Mar 31, 2026 | 10-Q · May 8, 2026 | view |
| RANI | Rani Therapeutics Holdings, Inc. | 11.9 mo | medium | $18.62M | $1.56M | 12mo · Dec 31, 2025 | 10-K · Mar 26, 2026 | view |
| VHC | VirnetX Holding Corp | 11.9 mo | medium | $15.55M | $1.30M | 12mo · Dec 31, 2025 | 10-K · Mar 24, 2026 | view |
| ALLR | Allarity Therapeutics, Inc. | 11.9 mo | medium | $14.69M | $1.24M | 12mo · Dec 31, 2025 | 10-K · Mar 30, 2026 | view |
| AXG | Solowin Holdings, Ltd. | 11.9 mo | medium | $8.78M | $740.7K | 6mo · Sep 30, 2025 | 6-K · Jan 9, 2026 | view |
| ASNS | ACTELIS NETWORKS INC | 11.9 mo | medium | $7.55M | $634.0K | 3mo · Mar 31, 2026 | 10-Q · May 14, 2026 | view |
| AEMD | AETHLON MEDICAL INC | 11.9 mo | medium | $6.96M | $583.1K | 9mo · Dec 31, 2025 | 10-Q · Feb 12, 2026 | view |
| EZRA | Reliance Global Group, Inc. | 11.9 mo | medium | $2.27M | $190.4K | 3mo · Mar 31, 2026 | 10-Q · May 7, 2026 | view |
How runway is computed
For each issuer, the latest reported us-gaap:NetCashProvidedByUsedInOperatingActivities duration fact and the latest us-gaap:CashAndCashEquivalentsAtCarryingValueinstant fact (at or before the OCF period's end date) are pulled directly from the XBRL fact store. Average monthly burn is computed as −OCF / months_in_period, where the period is inferred from the OCF duration (≈ 3 months for a quarterly fact, 12 for an annual). Months-of-runway is then cash / monthly_burn.
Severity bucketing: extreme = under 3 months, high = 3–6 months, medium = 6–12 months, low= 12+ months. Issuers with positive operating cash flow are excluded — they aren't running out of cash. Issuers reporting zero or negative cash balances are also excluded; those filers typically show up on the delinquent-filers or delisting screens with related distress signals.
The figure is a snapshot in time and assumes the average burn from the most recent reported period continues unchanged. Real burn rates change with revenue ramps, cost cuts, restructurings, and one-time items. Always cross-reference against the actual filing for context — the runway figure is a screening signal, not an underwriting conclusion.